The large biotech I worked for explicitly allocate
Post# of 148161
(Total Views: 795)
Posted On: 09/16/2020 1:15:28 AM
The large biotech I worked for explicitly allocated 2% of shares each year to executive comp - new and existing, with some y-t-y variation allowed.
This assumption, along with impacts of other financings, was used in the long range plan in forecasting shares outstanding. I took those presentations to the board and to ratings agencies - neither was offended.
Compare that to what NP is asking, and consider he has to build a "real" company from scratch..
Just my experience, quite a while ago.
This assumption, along with impacts of other financings, was used in the long range plan in forecasting shares outstanding. I took those presentations to the board and to ratings agencies - neither was offended.
Compare that to what NP is asking, and consider he has to build a "real" company from scratch..
Just my experience, quite a while ago.
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼